Business Wire | Feb 26, 2021 11:17AM EST

Certara to Present at the Barclays Global Healthcare Conference

Feb. 26, 2021

PRINCETON, N.J.--(BUSINESS WIRE)--Feb. 26, 2021--Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, CEO and Andrew Schemick, CFO will virtually present at the Barclays Global Healthcare Conference on Tuesday, March 9, 2021 at 11:30 a.m. ET.

A live webcast will be available on Certara's investor relations website at https://ir.certara.com and will be available for replay for 90 days thereafter.

About Certara

Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210226005476/en/

CONTACT: Investor Relations Contact: David Deuchler Gilmartin Group ir@certara.com

CONTACT: Media Contact: Elizabeth Tang, Ph.D. Finn Partners elizabeth.tang@finnpartners.com